1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Refractory Soft Tissue Sarcoma: new trials by email Literature Review of Refractory Soft Tissue Sarcoma trials Research Report on Refractory Soft Tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma Onivyde, Talazoparib, Temozolomide - Recurrent Solid Tumor, Recurrent Ewing Sarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 90 | 2021-06-09 | 2026-05-19 |
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas Itacitinib, Laboratory Biomarker Analysis - Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 27 | 2019-09-30 | 2024-05-08 |
Sarcoma (2) · Chondrosarcoma (1) · Hepatoblastoma (1) · Histiocytoma, Malignant Fibrous (1) · Leiomyosarcoma (1) · Liposarcoma, Myxoid (1) · Neoplasms (1) · Neuroblastoma (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Osteosarcoma (1) · Rhabdoid Tumor (1) · Rhabdomyosarcoma (1) · Sarcoma, Ewing (1) · Sarcoma, Synovial (1) · Wilms Tumor (1)
Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Muscle Tissue (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Histiocytoma (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Liposarcoma (1) · Male Urogenital Diseases (1) · Myosarcoma (1) · Neoplasms (1)
INCB039110 (1) · Temozolomide (1) · baricitinib (1) · irinotecan sucrosofate (1) · itacitinib (1) · talazoparib (1)
Fred Hutchinson Cancer Center (1) · St. Jude Children's Research Hospital (1)
United States (2) · Canada (1)
Lee Cranmer (1) · Sara Federico, MD (1)